Kwality Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kwality Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Kwality Pharmaceuticals Ltd.

26 Jul 2025

1144.65

-0.68%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Resignation of Mr. Kiran Kumar Verma as Independent Director of the company

pdf

Kwality Pharmaceuticals Ltd.

26 Jul 2025

1144.65

-0.68%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

1. Appointment of Mr. Vinod Kumar Sharma as Additional, non executive Independent director of the company 2. Resignation of Mr. Kiran Kumar Verma as Independent director of the company 3. Reconstitution of Audit Committee and Nomination & Remuneration Committee

pdf

Kwality Pharmaceuticals Ltd.

14 Jul 2025

1144.65

-0.68%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30-06-2025.

pdf

Kwality Pharmaceuticals Ltd.

27 Jun 2025

1144.65

-0.68%

SAST

Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window

BSE India

Trading window Closure

pdf

Kwality Pharmaceuticals Ltd.

05 Jun 2025

1144.65

-0.68%

Investor Presentation

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for FY 2025.

pdf

Kwality Pharmaceuticals Ltd.

27 May 2025

1144.65

-0.68%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

NEWSPAPER PUBLICATION OF FINANCIAL RESULTS FOR Q.E. AND YEAR ENDED 31ST MARCH 2025

pdf

Kwality Pharmaceuticals Ltd.

19 May 2025

1144.65

-0.68%

Result

Kwality Pharmaceuticals Ltd - 539997 - Audited Standalone And Consolidated Financial Results For The Quarter And …

BSE India

AUDITED FINANCIAL RESULTS FOR YEAR ENDED 31ST MARCH 2025

pdf

Kwality Pharmaceuticals Ltd.

19 May 2025

1144.65

-0.68%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Audited Financial Results (Standalone And Consolidated) …

BSE India

we wish to inform you that at the Board Meeting held today i.e. on Monday, May 19, 2025, the Board of Directors of the Company have inter alia Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year Ended 31st March, 2025. we are enclosing herewith: a. Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year Ended 31st March, 2025. b. Statement of Assets and Liabilities as at March 31, 2025 and Statement of Cash Flows for the Financial Year Ended 31st March, 2025. c. Declaration pursuant to Regulation 33(3) (d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the Annual Financial Results for the Financial Year ended on 31st March, 2025. d. Auditors reports on the Audited Financial Results on Standalone and Consolidated basis.

pdf

Kwality Pharmaceuticals Ltd.

07 May 2025

1144.65

-0.68%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Conclusion Of Regulatory Audit For Zimbabwe

BSE India

Kwality Pharma successfully concluded regulatory audit for Zimbabwe across its General, Beta Lactam, Cephalosporin and Oncology Units.

pdf

Kwality Pharmaceuticals Ltd.

06 May 2025

1144.65

-0.68%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Considering The Standalone & Consolidated Audited …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended on 31st March, 2025.

pdf

Is Kwality Pharmaceuticals Ltd. worth buying?

61 Votes:

Buy 73.77%

Sell 14.75%

Hold 11.48%